• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    8 Consumer Staples Stocks Moving In Tuesday's Intraday Session

    2/6/24 12:31:34 PM ET
    $DADA
    $HNST
    $REBN
    $STKH
    Computer Software: Programming Data Processing
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $DADA alert in real time by email

    Gainers

    • Dada Nexus (NASDAQ:DADA) stock moved upwards by 14.0% to $1.92 during Tuesday's regular session. The market value of their outstanding shares is at $501.7 million.
    • Honest Co (NASDAQ:HNST) shares increased by 12.67% to $3.2. The market value of their outstanding shares is at $305.5 million.
    • Steakholder Foods (NASDAQ:STKH) stock moved upwards by 11.61% to $0.72. The market value of their outstanding shares is at $19.5 million.

    Losers

    • Reborn Coffee (NASDAQ:REBN) stock fell 30.6% to $2.67 during Tuesday's regular session. The market value of their outstanding shares is at $7.2 million.
    • DDC Enterprise (AMEX:DDC) shares declined by 25.46% to $2.05. The market value of their outstanding shares is at $39.0 million.
    • African Agriculture Hldgs (NASDAQ:AAGR) stock declined by 12.79% to $0.87. The market value of their outstanding shares is at $50.3 million.
    • 22nd Century Group (NASDAQ:XXII) stock decreased by 11.4% to $0.16. The market value of their outstanding shares is at $6.7 million.
    • Veru (NASDAQ:VERU) stock declined by 9.88% to $0.44. The company's market cap stands at $64.6 million. See Also: www.benzinga.com/money/best-consumer-defensive-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $DADA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DADA
    $HNST
    $REBN
    $STKH

    CompanyDatePrice TargetRatingAnalyst
    The Honest Company Inc.
    $HNST
    1/16/2026Overweight → Underweight
    Analyst
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    The Honest Company Inc.
    $HNST
    11/6/2025$3.00Buy → Hold
    Lake Street
    The Honest Company Inc.
    $HNST
    11/6/2025$6.00 → $3.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    8/7/2025$7.00 → $6.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    1/10/2025$6.00 → $7.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    12/17/2024$7.00Buy → Hold
    Loop Capital
    The Honest Company Inc.
    $HNST
    11/13/2024$4.00 → $6.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $DADA
    $HNST
    $REBN
    $STKH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reborn Coffee Provides Operational Update on Reborn Logistics, Highlighting Operating Income Progress and 2026 Growth Outlook

    Reborn Logistics Subsidiary Reports Preliminary Unaudited Q4 2025 Revenue of $2.5 Million and Operating Income of $0.6 Million  Company Targets $15 Million in Reborn Logistics Revenue in 2026 BREA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (NASDAQ:REBN) (the "Company"), a leader in the specialty coffee market, today provided a business update on Reborn Logistics, its wholly owned logistics subsidiary established to strengthen supply chain infrastructure and support the Company's expanding domestic and international operations. Following the Company's September 16, 2025, announcement establishing Reborn Logistics, the Company believes the subsidiary will continue to bui

    2/12/26 8:30:00 AM ET
    $REBN
    Restaurants
    Consumer Discretionary

    The Honest Company to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    LOS ANGELES, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care products company dedicated to creating products for everyone—from babies to adults—that raise the standards of clean and bring joy to every moment, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company will host a conference call and webcast to review these results at 1:45pm PT/4:45pm ET on the same day. For those interested in participating in the conference call by phone, please click here. Following registration, dial-in details will be provided via email. To avoid delays, we encourage par

    2/11/26 4:05:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DADA
    $HNST
    $REBN
    $STKH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gentile Susan was granted 28,499 shares, increasing direct ownership by 10% to 305,791 units (SEC Form 4)

    4 - Honest Company, Inc. (0001530979) (Issuer)

    1/2/26 6:57:15 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Bayne Katie J was granted 27,580 shares, increasing direct ownership by 8% to 373,842 units (SEC Form 4)

    4 - Honest Company, Inc. (0001530979) (Issuer)

    1/2/26 6:45:51 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Hartung Jack was granted 29,418 shares, increasing direct ownership by 8% to 402,073 units (SEC Form 4)

    4 - Honest Company, Inc. (0001530979) (Issuer)

    1/2/26 6:29:33 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $DADA
    $HNST
    $REBN
    $STKH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Honest Company downgraded by Analyst

    Analyst downgraded Honest Company from Overweight to Underweight

    1/16/26 8:32:37 AM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Canaccord Genuity initiated coverage on Veru with a new price target

    Canaccord Genuity initiated coverage of Veru with a rating of Buy and set a new price target of $25.00

    12/18/25 9:11:57 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Honest Company downgraded by Lake Street with a new price target

    Lake Street downgraded Honest Company from Buy to Hold and set a new price target of $3.00

    11/6/25 7:38:39 AM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    $DADA
    $HNST
    $REBN
    $STKH
    SEC Filings

    View All

    SEC Form 10-Q filed by Veru Inc.

    10-Q - VERU INC. (0000863894) (Filer)

    2/11/26 10:32:14 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Veru Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - VERU INC. (0000863894) (Filer)

    2/11/26 7:00:14 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Steakholder Foods Ltd.

    6-K - Steakholder Foods Ltd. (0001828098) (Filer)

    2/3/26 9:06:35 AM ET
    $STKH
    Packaged Foods
    Consumer Staples

    $DADA
    $HNST
    $REBN
    $STKH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DADA
    $HNST
    $REBN
    $STKH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rankowitz Michael L bought $84,351 worth of shares (150,000 units at $0.56), increasing direct ownership by 150% to 250,000 units (SEC Form 4)

    4 - VERU INC. (0000863894) (Issuer)

    2/20/25 10:00:11 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Firestone Lawrence bought $10,468 worth of shares (39,000 units at $0.27), increasing direct ownership by 256% to 54,250 units (SEC Form 4)

    4 - 22nd Century Group, Inc. (0001347858) (Issuer)

    9/12/24 5:00:14 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Firestone Lawrence bought $9,829 worth of shares (9,000 units at $1.09), increasing direct ownership by 144% to 15,250 units (SEC Form 4)

    4 - 22nd Century Group, Inc. (0001347858) (Issuer)

    5/31/24 4:05:20 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $DADA
    $HNST
    $REBN
    $STKH
    Financials

    Live finance-specific insights

    View All

    The Honest Company to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    LOS ANGELES, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care products company dedicated to creating products for everyone—from babies to adults—that raise the standards of clean and bring joy to every moment, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company will host a conference call and webcast to review these results at 1:45pm PT/4:45pm ET on the same day. For those interested in participating in the conference call by phone, please click here. Following registration, dial-in details will be provided via email. To avoid delays, we encourage par

    2/11/26 4:05:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th

    MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wednesday, February 11, 2026, at 8:00 a.m. ET to discuss its fiscal 2026 first quarter financial results and to provide a business update. The audio webcast will be accessible under the Home page and Investors page of the Company's website at www.verupharma.com. To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru I

    2/4/26 8:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DADA
    $HNST
    $REBN
    $STKH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Honest Company Inc.

    SC 13G/A - Honest Company, Inc. (0001530979) (Subject)

    11/14/24 6:19:57 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    11/14/24 5:56:57 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $DADA
    $HNST
    $REBN
    $STKH
    Leadership Updates

    Live Leadership Updates

    View All

    Reborn Coffee Announces the Formation of an Advisory Board and Appointment of Hisham Elkoustaf as Chair

    New Advisory Board to Drive Innovation and Growth Globally BREA, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (NASDAQ:REBN), a leader in the specialty coffee market, today announced the formation of its new advisory board to drive innovation and growth within the company and appointed Hisham Elkoustaf as its chair. The advisory boards will consist of a diverse group of professionals who will help to shape the strategic direction of Reborn Coffee and ensure that its remain committed to its values of sustainability and quality. Mr. Elkoustaf is an esteemed attorney with over 20 years of experience at the intersection of corporate law, economic development, and foreign poli

    10/23/25 9:00:01 AM ET
    $REBN
    Restaurants
    Consumer Discretionary

    22nd Century Announces First Shipments of Pinnacle VLN® Products to Top 5 C-Store Chain Locations Across 12 States

    Pinnacle VLN® from 22nd Century Gains 2nd Early Adopter to Join Popular Pinnacle Branded Conventional Cigarette Products Already Sold at Top-5 U.S. C-Store Chain MOCKSVILLE, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced the first shipments of its new Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine content cigarettes into distribution. These initial Pinnacle VLN® shipments will support a sales launch expected on September 1, 2025 at almost 1,000 locations across 12 states for a

    8/4/25 8:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Steakholder Foods Announces Signing of Investment and Convertible Loan Agreements, and Memorandum of Understanding for Proposed Transformative Acquisition of Twine Solutions

    Twine Shareholders Investing into Steakholder at $7 per ADS; More than 200% Premium Above Current ADS Price Strategic Acquisition Would Position Combined Company As Pioneering Force Across Food Tech and Textile Industries, Building Digital Printing and Dyeing Technology Powerhouse Since its foundation, Twine has installed more than 30 systems at leading brands, dye houses and textile fulfillers   Rehovot, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (NASDAQ:STKH), a leading innovator in alternative proteins and 3D printing technologies, today announced that it has signed both a non-binding MoU to acquire Twine Solutions Ltd., a transformative force in thread and yar

    6/11/25 8:00:00 AM ET
    $STKH
    Packaged Foods
    Consumer Staples